Clik here to view.
中国广州金沙洲医院新设质子治疗中心选用MEVION S250i
马萨诸塞州利特尔顿 (美国商业资讯)–Mevion Medical Systems欣然宣布，该公司已签署协议，向广州中医药大学金沙洲医院销售一台配备HYPERSCAN®笔束扫描的MEVION S250i质子治疗系统®。这将是广州-香港-澳门大湾区首台紧凑型质子治疗系统。签约仪式于2019年12月20日在金沙洲医院举行，近百位中国和国际肿瘤放疗专家和医院管理人员参加。...
View ArticleClik here to view.
PDC*line Pharma Raises €20 Million in Series B Financing Round
LIÈGE, Belgium & GRENOBLE, France PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, announces today the...
View ArticleClik here to view.
Phase 2 DESTINY-Gastric01 Trial of DS-8201 Versus Chemotherapy Met Primary...
TOKYO, MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced positive topline results from the pivotal phase 2...
View ArticleClik here to view.
Ningbo NewBay Medical Technology Co., Ltd. Announces a License Agreement with...
NINGBO, China Ningbo NewBay Medical Technology Co., Ltd., a subsidiary of Ningbo Tai Kang Medical Technology Co., Ltd. announced today that it has entered into a licensing agreement with Genentech,...
View ArticleClik here to view.
Krishnan Suthanthiran and His TeamBest Companies and Best Cure Foundation...
WASHINGTON & NEW YORK Congratulations to Dr. Dattatreyudu Nori M.D., F.A.C.R, F.A.C.R.O, F.A.S.T.R.O for his new appointment as the International Director of Apollo Cancer Centers in India and...
View ArticleClik here to view.
Sengenics, a Leading Precision Medicine Focused Company, to Present at the...
SINGAPORE Sengenics, a leading precision medicine focused company, today announced that Dr Arif Anwar, CEO of Sengenics, will present a company overview at the 2020 BIO CEO and Investor Conference....
View ArticleClik here to view.
Exelixis Announces Partner Takeda Files New Drug Application in Japan for...
ALAMEDA, Calif. Exelixis, Inc. (NASDAQ: EXEL) today announced that Takeda Pharmaceutical Company Limited (Takeda), its partner responsible for the clinical development and commercialization of...
View ArticleClik here to view.
AntiCancer Inc. to Target Its Oral Recombinant Methioninase Against 2019-nCoV...
SAN DIEGO Currently there are no therapies or vaccines for patients infected with 2019-nCoV coronavirus around the world. As the number of 2019-nCoV patients approaches 10,000 and more than 200...
View ArticleClik here to view.
Takeda Demonstrates Business Momentum, Accelerated Integration Synergies, and...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK): This press release features multimedia. View the full release here:...
View ArticleClik here to view.
武田薬品：良好なビジネスモメンタムおよび統合シナジーの加速化により、2019 年度通期業績予想は財務ベース営業利益の黒字転換を含む上方修正
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 (東証:4502) (NYSE:TAK)： 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：https://www.businesswire.com/news/home/20200203005853/ja/ 2019 年度第 3...
View ArticleClik here to view.
Clik here to view.
提供一贯有益的经验：全球调查数据显示，“Look Good Feel Better”项目对各种文化和地域均有影响力
华盛顿 (美国商业资讯)–全球癌症支持项目“Look Good Feel Better”今天分享了对项目参与者的第三次年度全球调研结果。2018/19年度“Look Good Feel Better”全球参与者调研收集了16个国家/地区26,000多名项目参与者的数据。结果证明，无论国家/地区或文化是什么，“Look Good Feel...
View ArticleClik here to view.
武田展现强劲业务发展势头，加速实现整合协同效应，并提升了2019财年指引，包括依据报告的运营利润转为正值
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TOKYO:4502, NYSE:TAK)： 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20200206005467/zh-CN/...
View ArticleClik here to view.
患者安全運動財団が2020年連邦保健IT計画の一環としてのデータ共有を支えるよう臨床医、患者擁護団体、病院、医療技術企業に呼び掛け
米カリフォルニア州アーバイン （ビジネスワイヤ） — 患者安全運動財団は、臨床医、患者擁護団体、病院、医療技術企業が2020年連邦保健IT計画の一環としてのデータ共有を支えるよう呼び掛けます。...
View ArticleClik here to view.
患者安全运动基金会号召临床医生、患者权益倡导者、医院和医疗技术公司支持2020年联邦卫生IT计划中的数据共享
加州尔湾 (美国商业资讯)–患者安全运动基金会(Patient Safety Movement Foundation)正号召临床医生、患者权益倡导者、医院和医疗技术公司支持2020年联邦卫生IT计划中的数据共享。 患者安全运动创始人、Masimo创始人、董事长兼首席执行官Joe...
View ArticleClik here to view.
OncoSec Announces that Nevada Court Denies Alpha Holdings’ Motion to Enjoin...
SAN DIEGO & PENNINGTON, N.J. OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today commented on the...
View ArticleClik here to view.
Lunaphore、PHCホールディングス株式会社が主導したシリーズC資金調達で2300万スイスフランを確保
スイス・ローザンヌ （ビジネスワイヤ） — スイスのライフサイエンス企業としてがん研究・組織診断向けの革新的な次世代装置を開発しているLunaphore Technologies...
View ArticleClik here to view.
知临集团宣布用于神经母细胞瘤的再利用候选药物SACT-1取得显著进展并计划2020下半年提交IND
纽约 (美国商业资讯)–致力于开发创新疗法以解决全球未被满足的医疗需求的生物制药公司知临集团（纳斯达克股票代码：APM），宣布其再利用候选药物SACT-1相关的积极数据和开发进展，该药物用于治疗婴幼儿中的罕见儿童癌症——神经母细胞瘤。知临集团计划待当前的验证研究完成后，于2020年下半年循505（b）（2）途径向FDA提交SACT-1的IND申请1。...
View ArticleClik here to view.
Clik here to view.
NorthStar Medical Technologies Signs Letter of Intent with Clarity...
BELOIT, Wis. & SYDNEY NorthStar Medical Technologies, LLC (NorthStar), a global innovator in the production and distribution of radioisotopes used for medical imaging, and Clarity...
View Article